Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Terlipressin Versus Vasopressin Infusion in Septic Shock. A Randomized, Controlled, Pilot Trial. "THE TERLIVAP STUDY"

NCT00481572 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT00481572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00481572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Terlipressin Versus Vasopressin Infusion in Septic Shock. A Randomized, Controlled, Pilot Trial. "THE TERLIVAP STUDY"
Lead sponsor
University of Roma La Sapienza
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
December 31, 2007
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock